i think Adam's view is probably in the majority for scientists, drug developers and especially statistians. Retail investors follwoing the herd. This might be a good trade up as retail will follow for AD results, but in the end this is never going to make it to market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.